Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-138-3 | CAS number: 926-57-8
Endpoint summary
Administrative data
Description of key information
-Acute toxicity: oral: LD50=414 mg/kg bw (male rats); LD50=300 mg/kg bw (female rats) according to OECD TG 401
-Acute Toxicity: inhalation: LD50=546 ppm (male rats), no guideline followed
Key value for chemical safety assessment
Additional information
OECD SIDS, 2007:
Studies in Animals
Inhalation
The inhalation 4-hour LC50 of 1,3-DCB in the male rat ranged from 546 (Kwon and Waritz, 1968) to 756 ppm (2840 to 3930 mg/m³) (Barsegyan, 1969). At lethal levels, 1,3-DCB caused irregular breathing, lacrimation, salivation, and hyperemia of the ears. Histopathologic examination revealed hemorrhage of lungs, tracheitis, and cell degeneration in the liver, spleen, thymus, and lymph nodes; no changes were observed in the testes. Tubular degeneration of the kidneys was also noted (Kwon and Waritz, 1968). The 2-hour LC50 in the mouse was 846 ppm (4400 mg/m³) (Barsegyan, 1969).
Dermal
There are no rat or rabbit dermal LD50 studies available for 1,3-DCB.
Oral
The oral LD50 for 1,3-DCB was 300 and 414 mg/kg in fasted male and female rats, respectively (Bayer AG, 1991), and 1368 mg/kg in the non-fasted male rat (DuPont, 1982a). Clinical signs of toxicity included stained and wet fur, wet perineal area, diarrhea, weakness, hunched posture, alopecia, salivation, chromodacryorrhea, rough coat, sedation, and/or weight loss (Bayer AG, 1991; DuPont, 1982a). The pathology examinations of animals that died on study showed congested vessels of the stomach, reddened mucous membranes, reddened small intestine, and clear fluid in the stomach.
Studies in Humans
Inhalation
Exposure of workers to 1,3-DCB can cause dizziness and nausea (DuPont, 1993). Exposure details were not reported.
Conclusions
In rats, 1,3-DCB is acutely toxic via the inhalation and oral routes of exposure
Justification for classification or non-classification
On the basis of the test results the substance should be classified as Xn, R20/22 (Harmful; Harmful by inhalation and if swallowed) according to DSD, and Acute Tox 3 (Toxic if swallowed and if inhaled, H301, H331) according to CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
